BEYOND: a randomised controlled trial comparing efficacy and safety of individualised follitropin delta dosing in GnRH agonist versus antagonist protocols for first ovarian stimulation cycle

被引：0
|
作者：
Sordal, T. [1 ]
Ekerhovd, E. [2 ]
Cohlen, B. [3 ]
Schenk, M. [4 ]
Larsson, P. [5 ]
Lobo, R. [6 ]
Pinton, P. [6 ]
Pinborg, A. [7 ]
机构：
[1] Medicus AS, Reprod Med, Trondheim, Norway
[2] Sykehuset Telemark HF, Reprod Med, Telemark, Norway
[3] Isala Fertil Cente, Reprod Med, Overijssel, Netherlands
[4] Das Kinderwunsch Inst Schenk GmbH, Reprod Med, Dobl, Austria
[5] Ferring Pharmaceut, Global Biometr, Kastrup, Denmark
[6] Ferring Pharmaceut, Global Translat & Clin Res & Dev, Kastrup, Denmark
[7] Rigshosp, Fertil Clin, Copenhagen, Denmark
来源：
HUMAN REPRODUCTION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-131
引用
收藏
页数：2
相关论文
共 25 条
  • [1] BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle
    Lobo, Rita
    Soerdal, Terje
    Ekerhovd, Erling
    Cohlen, Ben
    Porcu, Eleonora
    Schenk, Michael
    Shufaro, Yoel
    Smeenk, Jesper
    Suerdieck, Moritz B.
    Pinton, Philippe
    Pinborg, Anja
    HUMAN REPRODUCTION, 2024, 39 (07) : 1481 - 1494
  • [2] Live-birth and neonatal outcomes from BEYOND, a randomised controlled trial comparing efficacy and safety of individualised follitropin delta dosing in GnRH agonist versus antagonist protocols
    Pinborg, A.
    Shufaro, Y.
    Porcu, E.
    Smeenk, J.
    Suerdieck, M.
    Larsson, P.
    Pinton, P.
    Lobo, R.
    HUMAN REPRODUCTION, 2023, 38
  • [3] A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy
    Xavier, P
    Gamboa, C
    Calejo, L
    Silva, J
    Stevenson, D
    Nunes, A
    Martinez-de-Oliveira, J
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (02): : 185 - 189
  • [4] A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
    Qiao, Jie
    Zhang, Yunshan
    Liang, Xiaoyan
    Ho, Tuong
    Huang, Hong-Yuan
    Kim, Sung-Hoon
    Goethberg, Marie
    Mannaerts, Bernadette
    Arce, Joan-Carles
    HUMAN REPRODUCTION, 2021, 36 (09) : 2452 - 2462
  • [5] Comparing clomiphene citrate/ flexible GnRH antagonist vs ultrashort flare GnRH agonist protocols for controlled ovarian stimulation in poor ovarian reserve patients
    Parhar, P.
    Mehta, N.
    Rao, D.
    Chaitanya, K.
    HUMAN REPRODUCTION, 2023, 38
  • [6] A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol
    Fernandez Sanchez, Manuel
    Visnova, Hana
    Larsson, Per
    Andersen, Claus Yding
    Filicori, Marco
    Blockeel, Christophe
    Pinborg, Anja
    Khalaf, Yacoub
    Mannaerts, Bernadette
    HUMAN REPRODUCTION, 2022, 37 (06) : 1161 - 1174
  • [7] Efficacy and safety of follitropin delta in an individualised dosing regimen: a randomised, assessor-blind, controlled phase 3 trial in IVF/ICSI patients (ESTHER-1)
    Andersen, A. Nyboe
    Arce, J. C.
    HUMAN REPRODUCTION, 2016, 31 : 315 - 315
  • [8] Comparison GnRH agonist short protocol and GnRH antagonist in Brazilian normoresponder patients undergoing their first cycle of controlled ovarian stimulation
    Arruda, Jalsi Tacon
    Approbato, Mario Silva
    Silva Maia, Monica Canedo
    da Silva, Tatiana Moreira
    de Mendonca, Carolina Rodrigues
    Ramos, Marisa de Sousa
    Rodrigues, Shirley Ribeiro
    Pires Brito, Maria Zelia
    Coelho de Aguiar, Coracy
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2013, 17 (05): : 304 - 309
  • [9] A PROSPECTIVE RANDOMISED STUDY COMPARING A GNRH-ANTAGONIST VERSUS A GNRH-AGONIST SHORT PROTOCOL FOR OVARIAN STIMULATION IN PATIENTS REFERRED FOR IVF
    Gordts, S.
    Puttemans, P.
    Campo, R.
    Valkenburg, M.
    Gordts, S.
    FERTILITY AND STERILITY, 2011, 96 (03) : S176 - S176
  • [10] A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
    Gordts, S.
    Van Turnhout, C.
    Campo, R.
    Puttemans, P.
    Valkenburg, M.
    Gordts, S.
    FACTS VIEWS AND VISION IN OBGYN, 2012, 4 (02): : 82 - 87
123